UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors

Frontiers in oncology, 2019-02, Vol.9, p.51-51

2019

Volltextzugriff (PDF)

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)

Current treatment options in oncology, 2022-03, Vol.23 (3), p.381-403

2022

Volltextzugriff (PDF)

Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice

Cancer immunology research, 2015-04, Vol.3 (4), p.333-344

2015

Volltextzugriff (PDF)

Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice

Oncoimmunology, 2017-09, Vol.6 (9), p.e1341031-e1341031

2017

Volltextzugriff (PDF)

A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma

Leukemia, 2021-10, Vol.35 (10), p.2994-2997

2021

Volltextzugriff (PDF)

Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin

Frontiers in immunology, 2023-09, Vol.14, p.1211505-1211505

2023

Volltextzugriff (PDF)

Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection

Rheumatology and therapy., 2024-02, Vol.11 (1), p.191-200

2024

Volltextzugriff (PDF)

Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity

Seminars in hematology, 2020-10, Vol.57 (4), p.201-212

2020

Volltextzugriff (PDF)

Regulation of histone modification and cryptic transcription by the Bur1 and Paf1 complexes

The EMBO journal, 2007-11, Vol.26 (22), p.4646-4656

2007

Volltextzugriff (PDF)

Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice

Journal for immunotherapy of cancer, 2021-07, Vol.9 (7), p.e002267

2021

Volltextzugriff (PDF)

Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease

Frontiers in immunology, 2022-12, Vol.13, p.1055497-1055497

2022

Volltextzugriff (PDF)

Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56 NK cells

Innate immunity (London, England), 2019-07, Vol.25

2019

Volltextzugriff (PDF)

Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56Dim NK cells

Innate immunity (London, England), 2019-07, Vol.25 (5), p.294-304

2019

Volltextzugriff (PDF)

Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma

Journal for immunotherapy of cancer, 2020-10, Vol.8 (2), p.e001238

2020

Volltextzugriff (PDF)

Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model

Oncoimmunology, 2019-01, Vol.8 (1), p.e1512455-e1512455

2019

Volltextzugriff (PDF)

The Bur1 Cyclin-Dependent Protein Kinase Is Required for the Normal Pattern of Histone Methylation by Set2

Molecular and Cellular Biology, 2006-04, Vol.26 (8), p.3029-3038

2006

Volltextzugriff (PDF)

Two Steps in Maf1-dependent Repression of Transcription by RNA Polymerase III

The Journal of biological chemistry, 2005-02, Vol.280 (8), p.6455-6462

2005

Volltextzugriff (PDF)

SUMO E3 ligase activity of TRIM proteins

Oncogene, 2011-03, Vol.30 (9), p.1108-1116

2011

Volltextzugriff (PDF)

Advances in cellular and humoral immunotherapy – implications for the treatment of poor risk childhood, adolescent, and young adult B‐cell non‐Hodgkin lymphoma

British journal of haematology, 2019-06, Vol.185 (6), p.1055-1070

2019

Volltextzugriff (PDF)

Optimizing Ex-Vivo Expanded NK Cell- Mediated Cellular Cytotoxicity By Obinutuzumab Combined with NKTR-255 in Burkitt Lymphoma (BL)

Blood, 2023-11, Vol.142 (Supplement 1), p.2063-2063

2023

Volltextzugriff (PDF)

Adoptive cellular therapy after hematopoietic stem cell transplantation

American journal of hematology, 2024-05, Vol.99 (5), p.910-921

2024

Volltextzugriff (PDF)

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide and Changes in Plasma Biomarkers in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Blood, 2023-11, Vol.142 (Supplement 1), p.2520-2520

2023

Volltextzugriff (PDF)

Modification of Expanded NK Cells with Chimeric Antigen Receptor mRNA for Adoptive Cellular Therapy

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1441, p.215

2016

Volltextzugriff (PDF)

Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma

Best practice & research. Clinical haematology, 2023-03, Vol.36 (1), p.101442-101442, Article 101442

2023

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Englisch
(120)
Chinesisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(38)
Humans
(20)
Oncology
(14)
Immunology
(12)
Hematology, Oncology And Palliative Medicine
(11)
Hematology
(9)
Animals
(8)
Biochemistry & Molecular Biology
(8)
Immunotherapy
(8)
Cytotoxicity
(7)
Adolescent
(6)
Child
(6)
Chimeric Antigen Receptor
(6)
Cytokines
(6)
Killer Cells, Natural - Immunology
(6)
Natural Killer Cells
(6)
Young Adult
(6)
Antibodies
(5)
Immunotherapy - Methods
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)

Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice

Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice

A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma

Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin

Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection

Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity

Regulation of histone modification and cryptic transcription by the Bur1 and Paf1 complexes

Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice

Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease

Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56 NK cells

Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56Dim NK cells

Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma

Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model

The Bur1 Cyclin-Dependent Protein Kinase Is Required for the Normal Pattern of Histone Methylation by Set2

Two Steps in Maf1-dependent Repression of Transcription by RNA Polymerase III

SUMO E3 ligase activity of TRIM proteins

Advances in cellular and humoral immunotherapy – implications for the treatment of poor risk childhood, adolescent, and young adult B‐cell non‐Hodgkin lymphoma

Optimizing Ex-Vivo Expanded NK Cell- Mediated Cellular Cytotoxicity By Obinutuzumab Combined with NKTR-255 in Burkitt Lymphoma (BL)

Adoptive cellular therapy after hematopoietic stem cell transplantation

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide and Changes in Plasma Biomarkers in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Treatment of Refractory Adenovirus (ADV) Infections Using Adv-Specific Cytotoxic T-Lymphocytes (CTLs) in Children, Adolescents and Young Adults (CAYA) Post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), Solid Organ Transplantation (SOT), or with Primary Immunodeficiency (PID)

Modification of Expanded NK Cells with Chimeric Antigen Receptor mRNA for Adoptive Cellular Therapy

Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma

Suchergebnisse filtern